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Abstract: The detailed chemical analysis of the methanol extract of Meripilus giganteus (Pers.)
P. Karst. led to the isolation of two new cerebrosides, mericeramides A (1) and B (2)
together with cerebroside B (3), ergosterol (4), 3β-hydroxyergosta-7,22-diene (5), cerevisterol (6),
3β-hydroxyergosta-6,8(14),22-triene (7), 3β-O-glucopyranosyl-5,8-epidioxyergosta-6,22-diene (8) and
(11E,13E)-9,10-dihydroxy-11,13-octadecadienoic acid (9). The structures of the compounds were
determined on the basis of NMR and MS spectroscopic analysis. Mericeramide A (1) is the first
representative of halogenated natural cerebrosides. The isolated fungal metabolites 1–9 were evaluated
for their antioxidant activity using the oxygen radical absorbance capacity (ORAC) assay. Compounds
2, 5 and 9 proved to possess considerable antioxidant effects, with 2.50 ± 0.29, 4.94 ± 0.37 and
4.27 ± 0.05 mmol TE/g values, respectively. The result obtained gives a notable addition to the
chemical and bioactivity profile of M. giganteus, highlighting the possible contribution of this species
to a versatile and balanced diet.
Keywords: Meripilus giganteus; Meripilaceae; cerebroside; steroids; antioxidant; ORAC assay
1. Introduction
Mushrooms have long been valued not only as tasty and nutritional foods, but also as important
tools of traditional medicine applied for treating several disease or alleviating symptoms. The edible
polypore species, Meripilus giganteus (Pers.) P. Karst.—commonly known as “giant polypore”—a
member of the family Meripilaceae [1], is characterized by its large-sized brownish-colored multi-capped
fruiting body, which is mostly found close to stumps or on the roots of living broadleaved trees.
Morphologically, the large compound basidiome of M. giganteus seems to be related to the well-known
“Maitake” medicinal mushroom (Grifola frondosa (Dicks.) Gray), but the former is less grayish on
the pileus, has smaller pores, and its pore surface becomes rapidly blackish when bruised or injured.
The “giant polypore” was described by Persoon (1794) in Germany, under the name Boletus giganteus
Pers. [2]; later this species was reported in several parts of Asia and North America suggesting
that M. giganteus is widely distributed throughout the Northern Hemisphere [3]. However, a former
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taxonomic study queried the occurrence of M. giganteus in North America [4], which statement is also
supported by the UNITE species hypothesis (SH) approach [5]. Consequently, former morphological
observations and analyses of the available barcoding sequences deposited in public databases (e.g.,
GenBank, UNITE) indicate that the true “giant polypore” is a Eurasian species, with widespread
distribution in Europe and toward Western Asia.
According to our search of the literature, several chemical and pharmacological studies have
been carried out to identify the bioactive compounds of this species. Multiple studies revealed that
M. giganteus contains several bioactive metabolites, including phenolic compounds, steroids, organic
acids, tocopherols, and fatty acids [6]. Previously it has been demonstrated that extracts of M. giganteus
possess notable antimicrobial and antioxidant properties [7,8]; moreover, a water-soluble glucan
isolated from the sporocarps of giant polypore exhibited not only hydroxide and superoxide radical
scavenging but also ferrous ion chelating activities [9]. Recently, Lenzi et al. demonstrated that the
ethanol extract of the mushroom exhibits pro-apoptotic and anti-proliferative effects in leukemic cell
lines [10]. The nutritional profile of giant polypore has also been investigated, which revealed high
concentrations of carbohydrates and proteins, but a lower fat content [8].
In our search for bioactive fungal metabolites, we aimed to perform a detailed chemical examination
of M. giganteus in order to identify its characteristic constituents.
2. Results and Discussion
The mycochemical investigation of the methanol extract obtained from sporocarps of M. giganteus
resulted in the identification of nine compounds (1–9) (Figure 1). The fungal extract was first subjected
to solvent–solvent partition between aqueous MeOH and n-hexane, followed by extraction with
chloroform. The resulted n-hexane and chloroform extracts were separated using a combination of
flash column chromatography, preparative TLC and normal phase HPLC, to obtain compounds 1–9.
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The consecutive analysis of the HRMS and NMR data led to the conclusion that 1 and 2 are new
cerebrosides possessing the structures shown in Figure 1. These structural conclusions are based on
the following arguments.
HRMS data suggested elemental compositions of C42H81O11N and of C41H79ClO10N for 1 and 2,
respectively. The spectroscopic characteristics of 1 and 2 were very similar to those of cerebroside B
(3) isolated from this species as well, and identified on the basis of NMR and MS data by comparing
them to those reported earlier in the literature [11–13]. Apart from the resonances assigned to C7–C9
moiety, compounds 1 and 2 revealed highly similar spectral features in the 1H and 13C NMR spectra
in comparison with those of 3. The most significant differences were observed in the resonances
assignable to the middle of the sphingadienine chain. Thus, instead of the resonances due to the double
bond between C-8 and C-9 (5.14/125.0 (C-8), 136.9 (C-9)) in 3, in compounds 1 and 2, spectral features
suggested the presence of a methine group (3.47/74.8 and 75.0 ppm in 1 and 3.74/70.8 ppm in 2) and
a quaternary carbon (at 80.2 and 75.8 ppm in the 13C NMR spectrum of 1 and 2, respectively) both
bound to heteroatoms. In parallel, the resonances assigned to C-19 methyl groups showed significant
displacements both in 1 (1.06/18.6 ppm) and in 2 (1.20/22.4 ppm) compared to that in 3 (1.60/16.3
ppm). Furthermore, the additional 3H-singlet at 3.17 ppm in the 1H NMR spectrum of 1 (showing
correlation with the 49.6 ppm 13C resonance in the HSQC spectrum), indicated the presence of an
additional methoxy group in 1. Based on these findings, and considering the elemental compositions
and the observed HMBC correlations of H-6 with C-8, H-8 with C-6, C-10 and C-19 together with
those of H-19 with C-8, C-9 and C-10 (see complete assignments in Table 1), 8-hydroxy-9-methoxy and
8-chloro-9-hydroxy cerebroside structures (Figure 1) were proposed for 1 and 2, respectively.
Unfortunately, the absolute stereochemistry of 1 and 2 could not be determined from the collected
NMR data. However, except C-8 and C-9 centers, the highly similar 1H and 13C NMR features of 1
and 2 in comparison with the appropriate values of 3 suggested similar stereochemistry for the chiral
centers of the sugar moieties and the C-2, C-3 and C-2′ centers in all three compounds. Moreover, in
the case of 1, the 13C resonances assigned for the C4–C8 moiety were split into two peaks with a ca. 1:1
ratio. This suggested that 1 was isolated as a mixture of C-8 or/and C-9 epimers. Similar resonance
splitting was described by Qi et al. [14] in the case of the 8,9-dihydroxy analogues reported as the
oxidation products of cerebroside B, using OsO4 as the oxidizing agent. Interestingly, similar resonance
splitting was not observed in case of 2.
Ergosterol (4) and 3β-hydroxyergosta-7,22-diene (5) were structurally identified by comparing
the chromatographic and spectral characteristics to those of reference standards. Cerevisterol (6),
3β-hydroxyergosta-6,8(14),22-triene (7), and 3β-O-glucopyranosyl-5,8-epidioxyergosta-6,22-diene
(8) and (11E,13E)-9,10-dihydroxy-11,13-octadecadienoic acid (9) reported here were structurally
characterized on the basis of HRMS, MS-MS and standard one and two dimensional NMR
data in comparison to those reported in the literature. Thus, the NMR spectroscopic data
obtained for compounds 6–9 were found to be in good agreement with those reported earlier
in another solvent [15–17]. Unfortunately, with the data at hand, the absolute stereochemistry of
(11E,13E)-9,10-dihydroxy-11,13-octadecadienoic acid (9) could not be determined. In the case of
3β-hydroxyergosta-6,8(14),22-triene (7), the obtained 1H NMR chemical shifts and coupling constants
were in excellent agreement with the reported fragmentary 1H NMR information [18]. The complete 1H
and 13C NMR assignments for these already-reported compounds are provided in the Supplementary
Materials, except for the 1H and 13C NMR assignments of 3, which are listed in Table 1 to facilitate the
discussion on the structural characterization of 1 and 2.
The identified novel constituents (1–2) belong to the group of cerebrosides, classified as neutral
glycosphingolipids which can be found in animals, plants, and fungi, the latter being particularly
rich in such compounds. Though several halogenated natural products have been discovered in the
last decades, compound 2 is the first member of halogenated cerebrosids. There is growing evidence,
that several groups of organisms including fungi are producing halogenated organic compounds by
their specific metabolism [19]. It is fairly improbable that chloroform known as the most frequently
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used halogenated non-polar solvent in extraction and isolation of natural products would serve as a
halogenation agent; its distinctive stability makes chloroform an appropriate solvent for extractions
and in organic reactions with a considerable limitation as reaction partner. Moreover, the close relative
compound of chloroform, dichloromethane is extensively applied in pharmaceutical and food industry,
for e.g. in the decaffeination of coffee and tea and in the extraction of different flavorings [20].
Table 1. 1H and 13C NMR assignments of 1, 2 and 3 (CD3OD, 500 MHz (1 and 2) and 800 MHz (3)).
cmpd 1 2 3
13C 1H mult. (J, Hz) 13C 1H mult. (J, Hz) 13C 1H mult. (J, Hz)
(δ, ppm) (δ, ppm) (δ, ppm)
1 a 69.8 4.10 dt (10.2, 6.1) 69.9 4.11 dt (10.3, 6.4) 69.9 4.12 m
1 b 69.8 3.72 dd (10.2, 3.5) 69.9 3.72 m 69.9 3.71 dd (10.4, 3.6)
2 54.8 3.99 m 54.7 4.00 m 54.7 3.99 m
3 73.1/73.1 * 4.17/4.17 t (7.0) 72.9 4.16 t (7.6) 73.0 4.13 m
4 131.19/131.29 * 5.53 m 132.3 5.54 dd (15.4, 7.2) 131.2 5.48 dd (15.5, 7.5)
5 134.95/135.04 * 5.76 m 133.7 5.72 dt (15.4, 7.2) 134.8 5.74 dtd (15.4, 6.6, 0.7)
6 a 31.0 2.06 m 31.4 2.11 m 28.8 2.07 m
6 b 31.0 2.31 m 31.4 2.39 m
7 a 31.6 1.65 m 32.9 1.64 m 34.0 2.05 m
7 b 31.6 1.32 m 32.9 2.11 m
8 74.8/75.0 * 3.47 dd (10.3, 5.5) 70.8 3.74 m 125.0 5.14 tq (6.7, 1.0)
9 80.2 75.6 136.9
10 a 35.2 1.62 m 40.9 1.64 m 40.9 1.97 t (7.5)
10 b 35.2 1.49 m 40.9 1.59 m
11 24.0 1.32 m 24.1 1.38 m 29.3 1.39 m
12–15′ 30.9 1.30 m 30.9 1.29 m 30.5 1.29 m
16 33.2 1.28 m 33.2 1.29 m 33.2 1.31 m
17 23.9 1.32 m 24.0 1.32 m 23.9 1.31 m
18 14.6 0.90 t (6.9) 14.6 0.90 t (6.9) 14.6 0.90 t (7.1)
19 18.6 1.06 s 22.4 1.20 s 16.3 1.59 d (1.0)
20 49.6 3.17 s
1′ 177.4 177.4 177.3
2′ 73.2 3.99 m 73.2 3.99 m 73.2 3.98 m
3′ a 36.0 1.72 m 36.0 1.72 m 36.0 1.71 m
3′ b 36.0 1.55 m 36.0 1.55 m 36.0 1.55 m
4′ 26.4 1.42 m 26.4 1.42 m 26.3 1.40 m
5′–13′ 30.9 1.30 m 30.6 1.31 m 30.7 1.31 m
14′ 33.2 1.28 m 33.2 1.29 m 33.2 1.29 m
15′ 23.9 1.32 m 23.9 1.32 m 23.9 1.31 m
16′ 14.6 0.90 t (6.9) 14.6 0.90 t (6.9) 14.6 0.90 t (7.1)
1” 104.9 4.27 d (7.9) 104.9 4.27 d (7.8) 104.9 4.26 d (7.8)
2” 75.1 3.19 t (8.3) 75.1 3.19 t (8.4) 75.1 3.19 dd (9.3, 7.8)
3” 78.0 3.35 m 78.1 3.36 m 78.0 3.35 m
4” 71.7 3.28 m 71.7 3.28 m 78.1 3.27 m
5” 78.1 3.28 m 78.1 3.27 m 71.7 3.27 m
6” a 62.8 3.66 m 62.8 3.66 m 62.8 3.67 dd (11.9, 5.5)
6” b 62.8 3.87 d (11.8) 62.8 3.87 d (11.8) 62.8 3.86 dd (11.9, 1.2)
* due to the presence of diastereomers.
Cerebrosides originating from fungi are conserved structures which consist of a ceramide
portion with 9-methyl-4,8-sphingadienine in amidic linkage to 2-hydroxyoctadecanoic or
2-hydroxyhexadecanoic acids, and a carbohydrate moiety, namely glucose or galactose. Several fungal
cerebrosides were isolated from the plant pathogens Fusarium graminearum [21], Fusarium solani [22],
but also from edible and/or medicinal mushrooms for, e.g., Clitocybe geotropa and Clitocybe nebularis [23],
Lentinus edodes [24], Polyporus squamosus [25], and Schizophyllum commune [26].
The isolated compounds 1–9 were examined in the ORAC assay to explore their potential antioxidant
properties (see Table 2). Among the identified fungal metabolites of M. giganteus, mericeramide B
(2), 3β-hydroxyergosta-7,22-diene (5), and (11E,13E)-9,10-dihydroxy-11,13-octadecadienoic acid (9)
demonstrated noteworthy antioxidant activity compared to the reference compound, ascorbic acid.
Previous studies revealed that compound 3 had no ORAC and lipid peroxide inhibiting property, but
exhibited a slight effect in 2,2,1-diphenyl-1-picrylhydrazyl (DPPH) and superoxide dismutase (SOD)-like
activity assays [27,28]. Wei et al. investigated the antioxidant activity of compounds isolated from
the medicinal mushroom Hericium erinaceus and experienced notable effects for cerevisterol (6) in the
ORAC assay [29], while Athanasakis et al. found moderate DPPH activity for 6 [30]. In another study
cerevisterol (6) identified in the mycelia of H. erinaceus proved to possess considerable activity in the
DPPH assay [31].
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Table 2. Antioxidant activity of compounds 1–9 isolated from M. giganteus.
Compound ORAC Antioxidant Activity (mmol TE/g)
1 1.81 ± 0.34
2 2.50 ± 0.29
3 1.69 ± 0.20
4 1.12 ± 0.06
5 4.94 ± 0.37
6 1.94 ± 0.08
7 1.65 ± 0.03
8 1.90 ± 0.05
9 4.27 ± 0.05
Ascorbic acid 6.96 ± 0.57
3. Materials and Methods
The chemicals used in the experiments were supplied by Sigma-Aldrich Hungary and Molar
Chemicals, Hungary. Flash chromatography was carried out on a CombiFlash® Rf+ Lumen instrument
with integrated UV, UV-VIS and ELS detection using RediSep Rf Gold Normal Phase Silica Flash
columns (4, 12 and 60 g) (Teledyne Isco, Lincoln, NE, USA). Normal-phase HPLC (NP-HPLC)
separations were performed on a Wufeng LC-100 Plus HPLC instrument equipped with a UV-VIS
detector (Shanghai Wufeng Scientific Instruments Co., Ltd., Shanghai, China) at 254 nm, using a Zorbax
SILs column (250 × 4 mm, 5 µm; Agilent Technologies, Santa Clara, CA, USA).
HRMS and MS-MS analyses were performed on a Thermo Velos Pro Orbitrap Elite (Thermo
Fisher Scientific, Waltham, MA, USA) system. The ionization method was ESI-operated in negative or
positive ion mode. The protonated (or deprotonated) molecular ion, as well as adduct ion peaks were
fragmented by CID at a normalized collision energy of 35%–45%. For the CID experiment, helium was
used as the collision gas. The samples were dissolved in methanol. Data acquisition and analysis were
accomplished with Xcalibur software version 4.0 (Thermo Fisher Scientific).
NMR spectra were recorded at 298 K on a Bruker 500 (Bruker Corporation, Billerica, MA, USA) or
a Varian 800 MHz (Varian, Inc., Palo Alto, CA, USA) NMR spectrometer, equipped with a liquid helium
cooled 5 mm TCI CryoProbe or with a 5 mm HCN 13C-enhanced salt tolerant cold probe, respectively.
CD3OD was used as a solvent in all cases. Chemical shifts were referenced to residual solvent signals
(3.31 ppm for 1H and 49.15 for 13C). Standard one- (1H and 13C) and two-dimensional (COSY, HSQC,
HMBC and ROESY) data were acquired in all cases, using the pulse sequences available in the Bruker
Topspin 3.5 p7 or in the VNMRJ 3.2 sequence libraries. For data interpretation and reporting the
ACD/Spectrus Processor 2017.1.3 software (ACDLabs, Toronto, ON, Canada) was used.
3.1. Mushroom Material
Samples of Meripilus giganteus were collected from the roots of living beech and hornbeam
in Mecsek Mts (Southern Transdanubia, Hungary) in September 2014 and 2015, near the villages
of Püspökszentlászló (46◦10′41” N, 18◦21′51” E), Óbánya (46◦13′08”N, 18◦23′51”E), and Bakonya
(46◦05′54” N, 18◦03′56” E), and in Visegrád Mts (Central Hungary), near the village of Pilismarót
(47◦44′19” N, 18◦50′43” E) in August 2016. The samples were identified based on macro- and
microscopic features. The different collections were combined for the preparative mycochemical
experiment. Voucher specimens have been deposited in the mycological collection of the Hungarian
Natural History Museum (BP 106949-51).
3.2. Extraction and Isolation
The fresh mushroom material (12 kg) was extracted with methanol (46 L) at room temperature.
After concentration, the MeOH extract (145 g) was dissolved in 50% aqueous MeOH and subjected to
solvent–solvent partition with n-hexane (5 × 400 mL). The n-hexane fraction (19.84 g) was subjected
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to flash chromatography on a silica gel column using a gradient system of n-hexane and acetone
(0%–45%; t = 60 min). Fractions with similar compositions were combined according to TLC monitoring
(A1-A15). The combined fraction A4 (1.8 g) was separated by flash chromatography using a mixture of
n-hexane and acetone (0%–25%; t = 60 min), with increasing polarity, to obtain compounds 4 (0.35 g)
and 5 (0.72 g). Fraction A6 (180 mg) was further separated by flash chromatography, applying an
n-hexane–acetone solvent system (0%–30%; t = 45 min), and finally purified on normal phase HPLC
using n-hexane–isopropanol (65:35) solvent system to obtain compound 6 (1.8 mg). The fractionation
of fraction A6 (141 mg) on a normal phase column applying an n-hexane–isopropanol solvent system
resulted in 1 (14.5 mg) and 2 (3.5 mg).
The chloroform soluble phase (7.79 g) was subjected to flash chromatography in multiple steps
on a silica gel column using a gradient system of chloroform–methanol (0–45%, t = 50 min) and
n-hexane–acetone (0% to 100%, t = 60 min). Fractions with similar compositions were combined
according to TLC monitoring (B1-B9). Fraction B4 (250 mg) was further separated by a combination
of flash chromatography (n-hexane–acetone 5% to 25%, t = 50 min) and preparative TLC using an
n-hexane–isopropanol (8:2) solvent system to obtain 7 (2.7 mg) and 9 (5.1 mg). Finally, the fractionation of
B7 (185 mg) by normal phase flash chromatography led to the separation of 8 (15.2 mg) and 3 (25.9 mg).
Mericeramide A (1): white, amorphous solid; 1H and 13C-NMR data see in Table 1; HRESIMS:
M + Na = 798.56859 (−2.0 ppm; C42H81O11NNa).
Mericeramide B (2): white, amorphous solid; 1H and 13C-NMR data see in Table 1; HRESIMS:
M + Na = 802.51988 (−1.0 ppm; C41H78O10NClNa).
3.3. ORAC Assay
The ORAC assay was carried out on a 96-well microplate according to the method described
by Mielnik et al. [32]. 20 µL of pure compounds of 0.01 mg/mL concentration were mixed with
60 µL of 2,2′-azobis(2-methyl-propionamidine)-dihydrochloride (AAPH) (12 mM final concentration)
and 120 µL of fluorescein solution (70 nM final concentrations), then the fluorescence was measured
over 3 h with 1.5-minute cycle intervals with a FlouStar Optima BMG Labtech plate-reader. All the
experiments were carried out in triplicate; (±)-6-hydroxy-2,5,7,8-tetramethyl-chromane-2-carboxylic
acid (Trolox) was used as standard. AAPH free radical and Trolox standard were purchased from
Sigma-Aldrich (Budapest, Hungary). Fluorescein was purchased from Fluka analytical (Tokyo, Japan).
The antioxidant capacity was expressed as mmol Trolox equivalent per g of compound (mmol TEg-1),
with the help of GraphPad Prism 6.07.
4. Conclusions
The current study represents an in-depth chemical analysis of Meripilus giganteus and a valuable
addition to future biological activity studies of this species. The combination of chromatographic
methods led to the identification of nine compounds including two novel monoglycosylceramides,
mericeramides A (1) and B (2). To the best of our knowledge, mericeramide A (1) is the first member of
the halogenated natural cerebrosides. The ORAC assay conducted to examine the antioxidant properties
of isolated metabolites 1–9 revealed that compounds 2, 5 and 9 possess considerable antioxidant effects.
In this way, the edible giant polypore, containing fungal metabolites with antioxidant properties, has
the potential for utilization as part of a healthy and varied diet.
Supplementary Materials: Supplementary materials are available online: Figures S1–S36.
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